| Dr Alexander Kraev, MD | |
|
801 N 29th St, Billings, MT 59101-0905 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Dr Alexander Kraev |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 18 Years |
| Location | 801 N 29th St, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841444197 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Billings Clinic | Billings, MT | Hospital |
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Billings Clinic | 6002993516 | 659 |
| Billings Clinic | 6002993516 | 659 |
News Archive
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
For people with brain disorders, whether from injury or disease, rehabilitation is a complex process. Neurosexuality is an emerging area of study and practice that focuses on the relationships between brain and sexual function in individuals with and without neurological disorders.
The different positions taken by various Republican governors on the health law's Medicaid expansion underscore the political divisions in play.
Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.
› Verified 2 days ago
| Entity Name | Billings Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326104845 PECOS PAC ID: 6002993516 Enrollment ID: O20080430000212 |
News Archive
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
For people with brain disorders, whether from injury or disease, rehabilitation is a complex process. Neurosexuality is an emerging area of study and practice that focuses on the relationships between brain and sexual function in individuals with and without neurological disorders.
The different positions taken by various Republican governors on the health law's Medicaid expansion underscore the political divisions in play.
Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Kraev, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Dr Alexander Kraev, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
For people with brain disorders, whether from injury or disease, rehabilitation is a complex process. Neurosexuality is an emerging area of study and practice that focuses on the relationships between brain and sexual function in individuals with and without neurological disorders.
The different positions taken by various Republican governors on the health law's Medicaid expansion underscore the political divisions in play.
Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.
› Verified 2 days ago
Dr. James John Morris, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Suite 400e, Billings, MT 59101 Phone: 406-238-6820 Fax: 406-238-6838 | |
Hewes D. Agnew, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1020 N 27th St, Billings, MT 59101 Phone: 406-238-2500 | |
Eric Blake Howell, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |